Active

Adjuvent & Co.

Switched

BE0864349083

Rechtspersoon Private limited company 1 establishment

Akenkaai 56, 1000 Brussel Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Active for

22 year, 5 months

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.

Gross margin

€ 21,282

▲ 91% vs 2024

Profit

Growing

€ 14,124

▲ 87% vs 2024

Debts

High

€ 55,136

▼ 18% vs 2024

Adjuvent & Co. from Brussel, company number BE0864349083, closed financial year 2025 with a result of € 14,124 after tax. For that financial year Adjuvent & Co. recorded a gross margin of € 21,282 and equity of € -30,413. Compared with financial year 2024, the result moved from € 7,567 to € 14,124. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What happened at Adjuvent & Co.?

What happened at Adjuvent & Co. in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 14,124 (▲ 87% vs 2024). Source: NBB ↗
  • New establishment in Brussel. KBO
  • Start of the company according to the CBE. KBO

In short

From € 6,141 profit in 2021 to € 14,124 profit in 2025.

Paid € 3,435 in corporate taxes since 2021.

Best year ever: 2025, with € 14,124 profit.

A new publication or filing at Adjuvent & Co.? We notify you, reason included.

Follow Adjuvent & Co.

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Mathias ERVYN
Amaury LAMBRECHT
Adjuvent & Co.

Behind Adjuvent & Co. are Mathias ERVYN and Amaury LAMBRECHT.

See the full network in the app

Directors

According to the 2025 annual accounts

Mathias ERVYN

Director

Amaury LAMBRECHT

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Akenkaai 56 box 82

1000 Brussel

2.136.597.818

Akenkaai 69 box 17G

1000 Brussel

Active since 26 March 2004

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0864.349.083
VAT number
BE 0864.349.083
Registered office
Akenkaai 56 bus 82, 1000 Brussel
Names & denominations
Adjuvent & Co.
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
26 March 2004
Peppol
Active · Active since 28 Jan 2026
Activities · NACE

Activiteiten van adviesbureaus op het gebied van public relations en communicatie

Adviesbureaus op het gebied van public relations en communicatie

Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten

Computerconsultancy-activiteiten

Frequently asked questions

What is the enterprise number of Adjuvent & Co.?
The enterprise number of Adjuvent & Co. is BE0864349083.
What is the address of Adjuvent & Co.?
The registered office of Adjuvent & Co. is located at Akenkaai 56 box 82, 1000 Brussel.
When was Adjuvent & Co. founded?
Adjuvent & Co. was founded on 26 March 2004.
What is the main activity of Adjuvent & Co.?
The main activity of Adjuvent & Co. is "Activiteiten van adviesbureaus op het gebied van public relations en communicatie" (NACE code 73300).
Does Adjuvent & Co. have a website?
No website is currently known for Adjuvent & Co..
How much profit did Adjuvent & Co. make in 2025?
Adjuvent & Co. posted a profit after taxes of € 14,124 in financial year 2025.
What is the revenue of Adjuvent & Co.?
As a small company, Adjuvent & Co. is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 21,282.
Where can I find the annual accounts of Adjuvent & Co.?
Adjuvent & Co. files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Adjuvent & Co.?
According to the 2025 annual accounts, the directors of Adjuvent & Co. are: Mathias ERVYN, Amaury LAMBRECHT.
Who owns Adjuvent & Co.?
Behind Adjuvent & Co. are Mathias ERVYN and Amaury LAMBRECHT.